Reports for TEVA CANADA LIMITED
Company Name
TEVA CANADA LIMITED
Shortage reports
Actual shortage:
214 (7%)
Anticipated shortage:
0 (0%)
Avoided shortage:
10 (0%)
Resolved:
2706 (92%)
2930
Discontinuation Reports
To be discontinued:
2 (1%)
Discontinued:
298 (99%)
Reversed:
0 (0%)
300
363 (11%)
99 (46%)
| Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
|---|---|---|---|---|---|---|
| TEVA-AMIODARONE | 200MG | TABLET | Resolved | 2020-10-15 | 2020-11-07 | 126519 |
| TEVA-AMIODARONE | 200MG | TABLET | Resolved | 2020-04-02 | 2020-05-14 | 110664 |
| TEVA-AMITRIPTYLINE | 25MG | TABLET | Resolved | 2018-03-13 | 2018-05-30 | 42619 |
| TEVA-AMITRIPTYLINE | 50MG | TABLET | Resolved | 2021-05-27 | 2021-08-06 | 140033 |
| TEVA-AMITRIPTYLINE | 50MG | TABLET | Resolved | 2021-06-03 | 2022-01-07 | 140405 |
| TEVA-AMITRIPTYLINE | 25MG | TABLET | Resolved | 2021-06-24 | 2022-01-07 | 141466 |
| TEVA-AMITRIPTYLINE | 10MG | TABLET | Resolved | 2017-03-14 | 2018-03-08 | 2427 |
| TEVA-AMITRIPTYLINE | 50MG | TABLET | Resolved | 2017-03-14 | 2017-05-23 | 2434 |
| TEVA-AMITRIPTYLINE | 50MG | TABLET | Resolved | 2017-03-14 | 2017-05-23 | 2437 |
| TEVA-AMITRIPTYLINE | 10MG | TABLET | Resolved | 2017-04-03 | 2018-03-08 | 5171 |
| TEVA-AMITRIPTYLINE | 10MG | TABLET | Resolved | 2020-07-16 | 2020-09-24 | 120503 |
| TEVA-AMITRIPTYLINE | 10MG | TABLET | Resolved | 2020-10-01 | 2020-10-24 | 125509 |
| TEVA-AMLODIPINE | 5MG | TABLET | Resolved | 2020-05-01 | 2020-07-10 | 113794 |
| TEVA-AMLODIPINE | 10MG | TABLET | Resolved | 2020-05-01 | 2020-07-10 | 113797 |
| TEVA-AMLODIPINE | 10MG | TABLET | Resolved | 2020-05-08 | 2020-07-10 | 114442 |
| TEVA-AMLODIPINE | 5MG | TABLET | Resolved | 2017-05-10 | 2018-03-13 | 9788 |
| TEVA-AMLODIPINE | 5MG | TABLET | Resolved | 2017-05-10 | 2018-03-13 | 9791 |
| TEVA-AMLODIPINE | 5MG | TABLET | Resolved | 2017-08-01 | 2018-03-13 | 17847 |
| TEVA-AMLODIPINE | 10MG | TABLET | Resolved | 2017-08-01 | 2018-03-13 | 17850 |
| TEVA-AMLODIPINE | 10MG | TABLET | Resolved | 2017-08-21 | 2018-03-13 | 19925 |
| Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
|---|---|---|---|---|---|---|
| TEVA-METOPROLOL | 50MG | TABLET | Discontinued | 2020-07-10 | 2020-07-10 | 119976 |
| TEVA-MIRTAZAPINE | 30MG | TABLET | Discontinued | 2025-03-20 | 2025-03-20 | 253165 |
| TEVA-MIRTAZAPINE | 30MG | TABLET | Discontinued | 2024-10-11 | 2024-10-11 | 240081 |
| TEVA-MIRTAZAPINE | 30MG | TABLET | Discontinued | 2021-02-12 | 2021-02-12 | 133908 |
| TEVA-NAPROXEN | 250MG | TABLET | Discontinued | 2017-06-27 | 2017-06-27 | 14055 |
| TEVA-NAPROXEN SODIUM DS | 550MG | TABLET | Discontinued | 2019-04-11 | 2019-04-11 | 81350 |
| TEVA-NORFLOXACIN | 400MG | TABLET | Discontinued | 2018-10-19 | 2018-10-19 | 65013 |
| TEVA-NYSTATIN | 100000UNIT | SUSPENSION | Discontinued | 2018-10-12 | 2018-10-12 | 63946 |
| TEVA-NYSTATIN | 100000UNIT | SUSPENSION | Discontinued | 2018-10-12 | 2018-10-12 | 63949 |
| TEVA-NYSTATIN | 100000UNIT | CREAM | Discontinued | 2020-07-10 | 2020-07-10 | 120056 |
| TEVA-OXYBUTYNIN | 5MG | TABLET | Discontinued | 2024-06-28 | 2024-06-29 | 231586 |
| TEVA-OXYBUTYNIN | 5MG | TABLET | Discontinued | 2024-10-11 | 2024-10-11 | 240078 |
| TEVA-PANTOPRAZOLE MAGNESIUM | 40MG | TABLET (DELAYED-RELEASE) | Discontinued | 2021-02-12 | 2021-02-12 | 133891 |
| TEVA-PAROXETINE | 10MG | TABLET | Discontinued | 2025-03-20 | 2025-03-20 | 253182 |
| TEVA-PAROXETINE | 10MG | TABLET | Discontinued | 2019-04-11 | 2019-04-11 | 81313 |
| TEVA-PAROXETINE | 20MG | TABLET | Discontinued | 2025-03-20 | 2025-03-20 | 253160 |
| TEVA-PAROXETINE | 30MG | TABLET | Discontinued | 2019-12-09 | 2019-12-09 | 100540 |
| TEVA-PAROXETINE | 20MG | TABLET | Discontinued | 2019-12-09 | 2019-12-09 | 100547 |
| TEVA-PAROXETINE | 10MG | TABLET | Discontinued | 2020-02-21 | 2020-02-21 | 106898 |
| TEVA-PAROXETINE | 30MG | TABLET | Discontinued | 2020-02-21 | 2020-02-21 | 106901 |